Reeve Emma bought PTCT
September 11, 2025 · Form 4 insider transaction
Reeve Emma bought 10,000 shares of PTC Therapeutics, Inc. at $25.69 per share, a transaction worth $256.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$25.69
Total value
$256.9K
InsiderReeve Emma
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 11, 2025
Filing dateSeptember 16, 2025
Shares owned after20,332
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.